ALHC240816C5000
- 4.80
- 0.000.00%
Alignment Healthcare Newsroom
Alignment Healthcare Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Herbalife (HLF), Alignment Healthcare (ALHC) and Vaxcyte (PCVX)
Alignment Healthcare Analyst Ratings
Piper Sandler Upgrades Alignment Healthcare to Overweight, Raises Price Target to $8
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Crinetics Pharmaceuticals (CRNX) and Alignment Healthcare (ALHC)
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Butterfly Network (BFLY) and Deciphera Pharmaceuticals (DCPH)
Alignment Healthcare Analyst Ratings
UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating
Buy Rating Affirmed for Alignment Healthcare Amid Strong Q1 Performance and Positive 2024/2025 Outlook
Alignment Healthcare Analyst Ratings
Piper Sandler Downgrades Alignment Healthcare to Neutral, Lowers Price Target to $6
The Latest Analyst Ratings For Alignment Healthcare
Alignment Healthcare Analyst Ratings
Buy Rating Affirmed for Alignment Healthcare Amidst Strong Q4 Performance and Positive 2024 Outlook
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), TG Therapeutics (TGTX) and Amicus (FOLD)
UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating
Alignment Healthcare (ALHC) Receives a Buy From TD Cowen
Alignment Healthcare Analyst Ratings
Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating
Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Alignment Healthcare (ALHC) and 10x Genomics (TXG)